VIA
MDGL icon

Vantage Investment Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Vantage Investment Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-128
Closed -$2K – 835
2016
Q3 		$2K Sell
128
-2
-2% -$19 ﹤0.01% 695
2016
Q2 		$1K Hold
130
– – ﹤0.01% 778
2016
Q1 		$1K Hold
130
– – ﹤0.01% 767
2015
Q4 		$2K Hold
130
– – ﹤0.01% 701
2015
Q3 		$8K Hold
130
– – ﹤0.01% 544
2015
Q2 		$10K Sell
130
-129
-50% -$10.8K 0.01% 480
2015
Q1 		$18K Buy
259
+129
+99% +$11.1K 0.01% 505
2014
Q4 		$12K Hold
130
– – 0.01% 468
2014
Q3 		$14K Hold
130
– – 0.01% 429
2014
Q2 		$19K Hold
130
– – 0.01% 388
2014
Q1 		$20K Buy
+130
New +$25.6K 0.01% 345

Other funds holding MDGL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return